148 related articles for article (PubMed ID: 10553153)
1. Development and overcoming of ATRA resistance in acute promyelocytic leukemia.
Lo Coco F
Haematologica; 1999 Nov; 84(11):961-2. PubMed ID: 10553153
[No Abstract] [Full Text] [Related]
2. Tretinoin in the treatment of acute promyelocytic leukemia.
Wong WM
Cancer Pract; 1996; 4(4):220-3. PubMed ID: 8900766
[No Abstract] [Full Text] [Related]
3. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells.
Awwad RT; Do K; Stevenson H; Fu SW; Lo-Coco F; Costello M; Campbell CL; Berg PE
Ann Hematol; 2008 Mar; 87(3):195-203. PubMed ID: 18026954
[TBL] [Abstract][Full Text] [Related]
4. Pituitary relapse of acute promyelocytic leukemia after ATRA.
Lugassy G; Halperin Y
Int J Hematol; 1998 Jul; 68(1):101-2. PubMed ID: 9713174
[No Abstract] [Full Text] [Related]
5. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?
Subramaniyam S; Nandula SV; Nichols G; Weiner M; Satwani P; Alobeid B; Bhagat G; Murty VV
Leukemia; 2006 Dec; 20(12):2193-5. PubMed ID: 17008891
[No Abstract] [Full Text] [Related]
6. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
[TBL] [Abstract][Full Text] [Related]
7. [Disseminated intravascular coagulation in malignant neoplasms].
Kato A
Rinsho Ketsueki; 2010 Jan; 51(1):37-43. PubMed ID: 20134138
[No Abstract] [Full Text] [Related]
8. Retinoic acid and arsenic for treating acute promyelocytic leukemia.
Zhou GB; Zhao WL; Wang ZY; Chen SJ; Chen Z
PLoS Med; 2005 Jan; 2(1):e12. PubMed ID: 15696202
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based therapy for leukemia: a lesson from ATRA therapy.
Naoe T
Nagoya J Med Sci; 2001 Nov; 64(3-4):103-8. PubMed ID: 11820331
[TBL] [Abstract][Full Text] [Related]
10. [Arsenic efficient in acute promyelocytic leukemia].
Lehmann S; Paul C
Lakartidningen; 1999 Dec; 96(50):5626-8. PubMed ID: 10643228
[TBL] [Abstract][Full Text] [Related]
11. [Lessons learned from differentiation therapy with all-trans retinoic acid in the JALSG APL studies].
Asou N
Rinsho Ketsueki; 2004 Feb; 45(2):115-24. PubMed ID: 15045819
[No Abstract] [Full Text] [Related]
12. Early relapse after non myeloablative allogeneic stem cell transplantation in a patient with acute promyelocytic leukemia in complete molecular remission.
Tavernier E; Thomas X
Indian J Cancer; 2003; 40(4):140-3. PubMed ID: 14716110
[TBL] [Abstract][Full Text] [Related]
13. [All-trans retinoic acid-induced erythema nodosum in acute promyelocytic leukemia].
Taguchi A; Takahashi T; Harima Y; Takemoto Y; Ando T; Nomiyama J; Matsubara A; Yujiri T; Tanizawa Y
Rinsho Ketsueki; 2005 Mar; 46(3):202-5. PubMed ID: 16447715
[TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
15. ATRA-induced myositis in induction therapy of acute promyelocytic leukemia.
Martínez-Chamorro C; Martínez E; Gil-Fernández JJ; Alonso A; Escudero A; Fernández-Rañada JM
Haematologica; 2002 Feb; 87(2):ECR08. PubMed ID: 11836177
[No Abstract] [Full Text] [Related]
16. The maturation of differentiation therapy.
Cheson BD
N Engl J Med; 1992 Aug; 327(6):422-4. PubMed ID: 1625719
[No Abstract] [Full Text] [Related]
17. Concomitant complete remission of APL and smoldering ATL following ATRA therapy in a patient with the two diseases simultaneously.
Tsukasaki K; Fujimoto T; Hata T; Yamada Y; Kamihira S; Tomonaga M
Leukemia; 1995 Oct; 9(10):1797-8. PubMed ID: 7564532
[No Abstract] [Full Text] [Related]
18. Scrotal ulceration during induction therapy of acute promyelocytic leukemia with ATRA.
Pavithran K; Arjun R; Aruna R; Thomas M
Am J Hematol; 2004 Apr; 75(4):260-1. PubMed ID: 15054825
[TBL] [Abstract][Full Text] [Related]
19. A case of acute promyelocytic leukemia showing transient thrombocytosis caused by increased interleukin-6 and thrombopoietin after treatment with all-trans retinoic acid and chemotherapy.
Kondo M; Nakabayashi Y; Sugiyama A; Tominaga T; Shinohara K
Gan To Kagaku Ryoho; 2009 May; 36(5):827-30. PubMed ID: 19461187
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.
Avvisati G; Lo Coco F; Mandelli F
Semin Hematol; 2001 Jan; 38(1):4-12. PubMed ID: 11172535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
